MARKETS
Markets

EXCLUSIVE: Co-Diagnostics Marks New Milestone as India TB Test Clinical Studies Begin

Jul 22, 2026 · 08:46 AM ET· updated 1h ago
EXCLUSIVE: Co-Diagnostics Marks New Milestone as India TB Test Clinical Studies Begin

Co-Diagnostics' India joint venture CoSara has started clinical studies for its rapid TB PCR test, advancing deployment of its point-of-care platform.

Share
Why It Matters

Co-Diagnostics started real-world testing of a fast TB test in India through a partner company. This shows the company is moving forward with a new product, so watch whether the test works well and gets used by doctors.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.